Vasopressin: Behavioral roles of an "original" neuropeptide

Progress in Neurobiology

Volumn 84, Issue 1, 2008, Pages 1-24

  Caldwell, Heather K ^a   Lee, Heon Jin ^a   Macbeth, Abbe H ^a   Young III, W Scott ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Affiliation; Aggression; Anxiety; Avpr1a; Avpr1b; Behavior; Circadian; Hippocampus; Knockout; Learning; Maternal behavior; Memory; Oxytocin; Paraventricular; Review; Stress; Suprachiasmatic; Supraoptic; Transgenic

Indexed keywords

1 [5 CHLORO 1 (2,4 DIMETHOXYLPHENYLSULFONYL) 2,3 DIHYDRO 3 (2 METHOXYPHENYL) 2 OXO 1H INDOL 3 YL] 4 HYDROXY N,N DIMETHYL 2 PYRROLIDINECARBOXAMIDE; DESMOPRESSIN; DEXAMETHASONE; NEUROPEPTIDE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; VASOPRESSIN; VASOPRESSIN RECEPTOR; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1A RECEPTOR; VASOPRESSIN V1B RECEPTOR; VASOPRESSIN V2 RECEPTOR;

AGGRESSION; ANXIETY; BEHAVIOR; BRAIN; DEPRESSION; EVOLUTION; GENE INACTIVATION; HORMONE STRUCTURE; HUMAN; LEARNING; MATERNAL CARE; MEMORY; NONHUMAN; PARENTAL BEHAVIOR; PATERNAL BEHAVIOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECOGNITION; REGULATORY MECHANISM; REVIEW; SCIENTIFIC LITERATURE; SEX DIFFERENCE; SEXUAL BEHAVIOR; SOCIAL BEHAVIOR; SOCIAL STATUS; SPATIAL MEMORY; STRESS; SUPRACHIASMATIC NUCLEUS; TRANSGENICS;

AGGRESSION; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MEMORY; RECEPTORS, VASOPRESSIN; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL; VASOPRESSINS;

EID: 37149016771     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2007.10.007     Document Type: Review

References (321)

1. Aarde S.M., and Jentsch J.D. Haploinsufficiency of the arginine-vasopressin gene is associated with poor spatial working memory performance in rats. Horm. Behav. 49 (2006) 501-508
2. Acher R. Structure evolution and processing adaptation of neurohypophysial hormone-neurophysin precursors. Prog. Clin. Biol. Res. 342 (1990) 1-9
3. Acher R., and Chauvet M.T. La structure de la vasopressine de boeuf. Biochim. Acta (Amst.) 12 (1953) 487-488
4. Aguilera G., Pham Q., and Rabadan-Diehl C. Regulation of pituitary vasopressin receptors during chronic stress: relationship to corticotroph responsiveness. J. Neuroendocrinol. 6 (1994) 299-304
5. Aguilera G., and Rabadan-Diehl C. Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat. Exp. Physiol. 85 Spec. No. (2000) 19S-26S
6. Aguilera G., and Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul. Pept. 96 (2000) 23-29
7. Albers H.E., Dean A., Karom M.C., Smith D., and Huhman K.L. Role of V1a vasopressin receptors in the control of aggression in Syrian hamsters. Brain Res. 1073/1074 (2006) 425-430
8. Albers H.E., Liou S.Y., and Ferris C.F. Testosterone alters the behavioral response of the medial preoptic-anterior hypothalamus to microinjection of arginine vasopressin in the hamster. Brain Res. 456 (1988) 382-386
9. Albers H.E., Rowland C.M., and Ferris C.F. Arginine-vasopressin immunoreactivity is not altered by photoperiod or gonadal hormones in the Syrian hamster (Mesocricetus auratus). Brain Res. 539 (1991) 137-142
10. Albrecht U., and Eichele G. The mammalian circadian clock. Curr. Opin. Genet. Dev. 13 (2003) 271-277
11. Alescio-Lautier B., Paban V., and Soumireu-Mourat B. Neuromodulation of memory in the hippocampus by vasopressin. Eur. J. Pharmacol. 405 (2000) 63-72
12. Alescio-Lautier B., Rao H., Paban V., Devigne C., and Soumireu-Mourat B. Inhibition of the vasopressin-enhancing effect on memory retrieval and relearning by a vasopressin V1 receptor antagonist in mice. Eur. J. Pharmacol. 294 (1995) 763-770
13. Alescio-Lautier B., and Soumireu-Mourat B. Role of vasopressin in learning and memory in the hippocampus. Prog. Brain Res. 119 (1998) 501-521
14. Alves S.E., Lopez V., McEwen B.S., and Weiland N.G. Differential colocalization of estrogen receptor beta (ERbeta) with oxytocin and vasopressin in the paraventricular and supraoptic nuclei of the female rat brain: an immunocytochemical study. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 3281-3286
15. Amico J.A., Mantella R.C., Vollmer R.R., and Li X. Anxiety and stress responses in female oxytocin deficient mice. J. Neuroendocrinol. 16 (2004) 319-324
16. Antoni F.A. Novel ligand specificity of pituitary vasopressin receptors in the rat. Neuroendocrinology 39 (1984) 186-188
17. Antoni F.A., and Chadio S.E. Essential role of magnesium in oxytocin-receptor affinity and ligand specificity. Biochem. J. 257 (1989) 611-614
18. Aoyagi, T., Birumachi, J. I., Hiroyama, M., Fujiwara, Y., Sanbe, A., et al., 2007. Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice. Endocrinology [Epub February 15].
19. Appenrodt E., Schnabel R., and Schwarzberg H. Vasopressin administration modulates anxiety-related behavior in rats. Physiol. Behav. 64 (1998) 543-547
20. Aragona B.J., Liu Y., Curtis J.T., Stephan F.K., and Wang Z. A critical role for nucleus accumbens dopamine in partner-preference formation in male prairie voles. J. Neurosci. 23 (2003) 3483-3490
21. Aragona B.J., Liu Y., Yu Y.J., Curtis J.T., Detwiler J.M., et al. Nucleus accumbens dopamine differentially mediates the formation and maintenance of monogamous pair bonds. Nat. Neurosci. 9 (2006) 133-139
22. Aragona B.J., and Wang Z. The prairie vole (Microtus ochrogaster): an animal model for behavioral neuroendocrine research on pair bonding. Ilar. J. 45 (2004) 35-45
23. Askew A., Gonzalez F.A., Stahl J.M., and Karom M.C. Food competition and social experience effects on V1a receptor binding in the forebrain of male Long-Evans hooded rats. Horm. Behav. 49 (2006) 328-336
24. Bachner-Melman R., Dina C., Zohar A.H., Constantini N., Lerer E., et al. AVPR1a and SLC6A4 gene polymorphisms are associated with creative dance performance. PLoS Genet. 1 (2005) e42
25. Bachner-Melman R., Zohar A.H., Elizur Y., Nemanov L., Gritsenko I., et al. Association between a vasopressin receptor AVPR1A promoter region microsatellite and eating behavior measured by a self-report questionnaire (Eating Attitudes Test) in a family-based study of a nonclinical population. Int. J. Eat. Disord. 36 (2004) 451-460
26. Bales K.L., Kim A.J., Lewis-Reese A.D., and Sue Carter C. Both oxytocin and vasopressin may influence alloparental behavior in male prairie voles. Horm. Behav. 45 (2004) 354-361
27. Bamshad M., Novak M.A., and de Vries G.J. Cohabitation alters vasopressin innervation and paternal behavior in prairie voles (Microtus ochrogaster). Physiol. Behav. 56 (1994) 751-758
28. Bankir L. Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Cardiovasc. Res. 51 (2001) 372-390
29. Barberis C., Morin D., Durroux T., Mouillac B., Guillon G., et al. Molecular pharmacology of AVP and OT receptors and therapeutic potential. Drug News Perspect. 12 (1999) 279-292
30. Baron-Cohen S., and Belmonte M.K. Autism: a window onto the development of the social and the analytic brain. Annu. Rev. Neurosci. 28 (2005) 109-126
31. Barreca T., Franceschini R., Siani C., Messina V., Francaviglia N., et al. Diurnal pattern of plasma and cerebrospinal-fluid vasopressin levels in hydrocephalic patients: absence of a circadian rhythm and of a correlation between plasma and cerebrospinal-fluid variations. Horm. Res. 30 (1988) 28-31
32. Beckwith B.E., Couk D.I., and Till T.S. Vasopressin analog influences the performance of males on a reaction time task. Peptides 4 (1983) 707-709
33. Beckwith B.E., Petros T.V., Bergloff P.J., Swenson R.R., and Paulson R. Failure of posttrial administration of vasopressin analogue (DDAVP) to influence memory in healthy, young, male volunteers. Peptides 16 (1995) 1327-1328
34. Beckwith B.E., Till R.E., and Schneider V. Vasopressin analog (DDAVP) improves memory in human males. Peptides 5 (1984) 819-822
35. Bester-Meredith J.K., and Marler C.A. Vasopressin and aggression in cross-fostered California mice (Peromyscus californicus) and white-footed mice (Peromyscus leucopus). Horm. Behav. 40 (2001) 51-64
36. Bester-Meredith J.K., and Marler C.A. Vasopressin and the transmission of paternal behavior across generations in mated, cross-fostered Peromyscus mice. Behav. Neurosci. 117 (2003) 455-463
37. Bester-Meredith J.K., Martin P.A., and Marler C.A. Manipulations of vasopressin alter aggression differently across testing conditions in monogamous and non-monogamous Peromyscus mice. Aggress. Behav. (2005) 31
38. Bester-Meredith J.K., Young L.J., and Marler C.A. Species differences in paternal behavior and aggression in peromyscus and their associations with vasopressin immunoreactivity and receptors. Horm. Behav. 36 (1999) 25-38
39. Bielsky I.F., Hu S.B., Ren X., Terwilliger E.F., and Young L.J. The V1a vasopressin receptor is necessary and sufficient for normal social recognition: a gene replacement study. Neuron 47 (2005) 503-513
40. Bielsky I.F., Hu S.B., Szegda K.L., Westphal H., and Young L.J. Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice. Neuropsychopharmacology 29 (2004) 483-493
41. Bielsky I.F., Hu S.B., and Young L.J. Sexual dimorphism in the vasopressin system: lack of an altered behavioral phenotype in female V1a receptor knockout mice. Behav. Brain Res. 164 (2005) 132-136
42. Blanchard R.J., Griebel G., Farrokhi C., Markham C., Yang M., et al. AVP V1b selective antagonist SSR149415 blocks aggressive behaviors in hamsters. Pharmacol. Biochem. Behav. 80 (2005) 189-194
43. Blanchard R.J., Wall P.M., and Blanchard D.C. Problems in the study of rodent aggression. Horm. Behav. 44 (2003) 161-170
44. Bluthe R.M., Gheusi G., and Dantzer R. Gonadal steroids influence the involvement of arginine vasopressin in social recognition in mice. Psychoneuroendocrinology 18 (1993) 323-335
45. Bluthe R.M., Schoenen J., and Dantzer R. Androgen-dependent vasopressinergic neurons are involved in social recognition in rats. Brain Res. 519 (1990) 150-157
46. Bohus B., Ader R., and de Wied D. Effects of vasopressin on active and passive avoidance behavior. Horm. Behav. 3 (1972) 191-197
47. Bohus B., and de Wied D. The vasopressin deficient Brattleboro rats: a natural knockout model used in the search for CNS effects of vasopressin. Prog. Brain Res. 119 (1998) 555-573
48. Born J., Lange T., Kern W., McGregor G.P., Bickel U., et al. Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. 5 (2002) 514-516
49. Born J., Pietrowsky R., and Fehm H.L. Neuropsychological effects of vasopressin in healthy humans. Prog. Brain Res. 119 (1998) 619-643
50. Bosch O.J., Kromer S.A., and Neumann I.D. Prenatal stress: opposite effects on anxiety and hypothalamic expression of vasopressin and corticotropin-releasing hormone in rats selectively bred for high and low anxiety. Eur. J. Neurosci. 23 (2006) 541-551
51. Brownstein M.J., Russell J.T., and Gainer H. Synthesis, transport, and release of posterior pituitary hormones. Science 207 (1980) 373-378
52. Bruce H.M. An exteroceptive block to pregnancy in the mouse. Nature 184 (1959) 105
53. Buijs R.M., Swaab D.F., Dogterom J., and van Leeuwen F.W. Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat. Cell Tissue Res. 186 (1978) 423-433
54. Buijs R.M., van Eden C.G., Goncharuk V.D., and Kalsbeek A. The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system. J. Endocrinol. 177 (2003) 17-26
55. Buijs R.M., Wortel J., Van Heerikhuize J.J., Feenstra M.G., Ter Horst G.J., et al. Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur. J. Neurosci. 11 (1999) 1535-1544
56. Burbach J.P., Luckman S.M., Murphy D., and Gainer H. Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol. Rev. 81 (2001) 1197-1267
57. Caba M., Silver R., Gonzalez-Mariscal G., Jimenez A., and Beyer C. Oxytocin and vasopressin immunoreactivity in rabbit hypothalamus during estrus, late pregnancy, and postpartum. Brain Res. 720 (1996) 7-16
58. Caffe A.R., van Leeuwen F.W., and Luiten P.G. Vasopressin cells in the medial amygdala of the rat project to the lateral septum and ventral hippocampus. J. Comp. Neurol. 261 (1987) 237-252
59. Caldwell H.K., and Albers H.E. Short-photoperiod exposure reduces vasopressin (V1a) receptor binding but not arginine-vasopressin-induced flank marking in male Syrian hamsters. J. Neuroendocrinol. 15 (2003) 971-977
60. Caldwell H.K., and Albers H.E. Photoperiodic regulation of vasopressin receptor binding in female Syrian hamsters. Brain Res. 1002 (2004) 136-141
61. Caldwell H.K., and Albers H.E. Effect of photoperiod on vasopressin-induced aggression in Syrian hamsters. Horm. Behav. 46 (2004) 444-449
62. Caldwell H.K., Stewart J., Wiedholz L.M., Millstein R.A., Iacangelo A., et al. The acute intoxicating effects of ethanol are not dependent on the vasopressin 1a or 1b receptors. Neuropeptides 40 (2006) 325-337
63. Caldwell H.K., and Young III W.S. Oxytocin and vasopressin: genetics and behavioral impolications. In: Lim R. (Ed). Neuroactive Proteins and Peptides (2006), Springer, New York 573-607
64. Caldwell J.D., Greer E.R., Johnson M.F., Prange Jr. A.J., and Pedersen C.A. Oxytocin and vasopressin immunoreactivity in hypothalamic and extrahypothalamic sites in late pregnant and postpartum rats. Neuroendocrinology 46 (1987) 39-47
65. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463 (2003) 235-272
66. Carter C.S. Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinology 23 (1998) 779-818
67. Carter C.S. Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders?. Behav. Brain Res. 176 (2007) 170-186
68. Carter C.S., DeVries A.C., and Getz L.L. Physiological substrates of mammalian monogamy: the prairie vole model. Neurosci. Biobehav. Rev. 19 (1995) 303-314
69. Carter C.S., and Getz L.L. Monogamy and the prairie vole. Sci. Am. 268 (1993) 100-106
70. Chakrabarti S., and Fombonne E. Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am. J. Psychiatry 162 (2005) 1133-1141
71. Chan W.Y., Wo N.C., Stoev S.T., Cheng L.L., and Manning M. Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays. Exp. Physiol. 85 Spec. No. (2000) 7S-18S
72. Cho M.M., DeVries A.C., Williams J.R., and Carter C.S. The effects of oxytocin and vasopressin on partner preferences in male and female prairie voles (Microtus ochrogaster). Behav. Neurosci. 113 (1999) 1071-1079
73. Coccaro E.F., Kavoussi R.J., Hauger R.L., Cooper T.B., and Ferris C.F. Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. Arch. Gen. Psychiatry 55 (1998) 708-714
74. Compaan J.C., Buijs R.M., Pool C.W., De Ruiter A.J., and Koolhaas J.M. Differential lateral septal vasopressin innervation in aggressive and nonaggressive male mice. Brain Res. Bull. 30 (1993) 1-6
75. Cooper M.A., Karom M., Huhman K.L., and Albers H.E. Repeated agonistic encounters in hamsters modulate AVP V1a receptor binding. Horm. Behav. 48 (2005) 545-551
76. Crawley J.N. What's Wrong With My Mouse: Behavioral Phenotypine of Transgenic and Knockout Mice (2000), Wiley-Liss, New York
77. Croiset G., Nijsen M.J., and Kamphuis P.J. Role of corticotropin-releasing factor, vasopressin and the autonomic nervous system in learning and memory. Eur. J. Pharmacol. 405 (2000) 225-234
78. Crowley R.S., and Amico J.A. Gonadal steroid modulation of oxytocin and vasopressin gene expression in the hypothalamus of the osmotically stimulated rat. Endocrinology 133 (1993) 2711-2718
79. Dantzer R., Bluthe R.M., Koob G.F., and Le Moal M. Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology (Berlin) 91 (1987) 363-368
80. De Vries G.J., Best W., and Sluiter A.A. The influence of androgens on the development of a sex difference in the vasopressinergic innervation of the rat lateral septum. Brain Res. 284 (1983) 377-380
81. De Vries G.J., and Buijs R.M. The origin of the vasopressinergic and oxytocinergic innervation of the rat brain with special reference to the lateral septum. Brain Res. 273 (1983) 307-317
82. De Vries G.J., Buijs R.M., and Sluiter A.A. Gonadal hormone actions on the morphology of the vasopressinergic innervation of the adult rat brain. Brain Res. 298 (1984) 141-145
83. De Vries G.J., Buijs R.M., Van Leeuwen F.W., Caffe A.R., and Swaab D.F. The vasopressinergic innervation of the brain in normal and castrated rats. J. Comp. Neurol. 233 (1985) 236-254
84. De Vries G.J., and Miller M.A. Anatomy and function of extrahypothalamic vasopressin systems in the brain. Prog. Brain Res. 119 (1998) 3-20
85. de Wied D. The influence of the posterior and intermediate lobe of the pituitary and pituitary peptides on the maintenance of a conditioned avoidance response in rats. Int. J. Neuropharmacol. (1965) 16
86. de Wied D., Diamant M., and Fodor M. Central nervous system effects of the neurohypophyseal hormones and related peptides. Front Neuroendocrinol. 14 (1993) 251-302
87. Delville Y., Conklin L.S., and Ferris C.F. Differential expression of vasopressin receptor binding in the hypothalamus during lactation in golden hamsters. Brain Res. 689 (1995) 147-150
88. Delville Y., De Vries G.J., Schwartz W.J., and Ferris C.F. Flank-marking behavior and the neural distribution of vasopressin innervation in golden hamsters with suprachiasmatic lesions. Behav. Neurosci. 112 (1998) 1486-1501
89. Delville Y., Mansour K.M., and Ferris C.F. Serotonin blocks vasopressin-facilitated offensive aggression: interactions within the ventrolateral hypothalamus of golden hamsters. Physiol. Behav. 59 (1996) 813-816
90. Delville Y., Mansour K.M., and Ferris C.F. Testosterone facilitates aggression by modulating vasopressin receptors in the hypothalamus. Physiol. Behav. 60 (1996) 25-29
91. Dietrich A., and Allen J.D. Vasopressin and memory. I. The vasopressin analogue AVP4-9 enhances working memory as well as reference memory in the radial arm maze. Behav. Brain Res. 87 (1997) 195-200
92. Dietrich A., and Allen J.D. Vasopressin and memory. II. Lesions to the hippocampus block the memory enhancing effects of AVP4-9 in the radial maze. Behav. Brain Res. 87 (1997) 201-208
93. Dinan T.G., O'Brien S., Lavelle E., and Scott L.V. Further neuroendocrine evidence of enhanced vasopressin V3 receptor responses in melancholic depression. Psychol. Med. 34 (2004) 169-172
94. Dodt C., Pietrowsky R., Sewing A., Zabel A., Fehm H.L., et al. Effects of vasopressin on event-related potential indicators of cognitive stimulus processing in young and old humans. J. Gerontol. 49 (1994) M183-M188
95. du Vigneaud V. A Trail of Research (1952), Cornell University Press, Ithaca
96. du Vigneaud V., Gish D.T., and Katsoyannis P.G. A synthetic preparation possessing biological properties associated with arginine-vasopressin. J. Am. Chem. Soc. 76 (1954) 4751-4752
97. du Vigneaud V., Lawler H.C., and Popenoe E.A. Enzymic cleavage of glycinamide from vasopressin and a proposed structure for this pressor-antidiuretic hormone of the posterior pituitary. J. Am. Chem. Soc. 75 (1953) 4880-4881
98. du Vigneaud V., Ressler C., Swan J.M., Roberts C.W., and Katsoyannis P.G. The synthesis of oxytocin. J. Am. Chem. Soc. 76 (1954) 3115-3121
99. du Vigneaud V., Ressler C., and Trippett S. The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin. J. Biol. Chem. 205 (1953) 949-957
100. Dubois-Dauphin M., Theler J.M., Ouarour A., Pevet P., Barberis C., et al. Regional differences in testosterone effects on vasopressin receptors and on vasopressin immunoreactivity in intact and castrated Siberian hamsters. Brain Res. 638 (1994) 267-276
101. Ebner K., Wotjak C.T., Holsboer F., Landgraf R., and Engelmann M. Vasopressin released within the septal brain area during swim stress modulates the behavioural stress response in rats. Eur. J. Neurosci. 11 (1999) 997-1002
102. Ebner K., Wotjak C.T., Landgraf R., and Engelmann M. Forced swimming triggers vasopressin release within the amygdala to modulate stress-coping strategies in rats. Eur. J. Neurosci. 15 (2002) 384-388
103. Egashira N., Tanoue A., Higashihara F., Mishima K., Fukue Y., et al. V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze. Neurosci. Lett. 356 (2004) 195-198
104. Egashira N., Tanoue A., Matsuda T., Koushi E., Harada S., et al. Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice. Behav. Brain Res. 178 (2007) 123-127
105. Egashira N., Tanoue A., Tsujimoto G., Mishima K., Takano Y., et al. Vasopressin receptor knockout mice as an animal model of psychiatric disorders. Nihon Shinkei Seishin Yakurigaku Zasshi 26 (2006) 101-105
106. Engelmann M., Bures J., and Landgraf R. Vasopressin administration via microdialysis into the septum interferes with the acquisition of spatial memory in rats. Neurosci. Lett. 142 (1992) 69-72
107. Engelmann M., Ebner K., Landgraf R., and Wotjak C.T. Swim stress triggers the release of vasopressin within the suprachiasmatic nucleus of male rats. Brain Res. 792 (1998) 343-347
108. Engelmann M., Ebner K., Landgraf R., and Wotjak C.T. Effects of Morris water maze testing on the neuroendocrine stress response and intrahypothalamic release of vasopressin and oxytocin in the rat. Horm. Behav. 50 (2006) 496-501
109. Engelmann M., and Landgraf R. Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats. Physiol. Behav. 55 (1994) 145-149
110. Engelmann M., Wotjak C.T., Ebner K., and Landgraf R. Behavioural impact of intraseptally released vasopressin and oxytocin in rats. Exp. Physiol. 85 Spec. No. (2000) 125S-130S
111. Everts H.G., De Ruiter A.J., and Koolhaas J.M. Differential lateral septal vasopressin in wild-type rats: correlation with aggression. Horm. Behav. 31 (1997) 136-144
112. Everts H.G., and Koolhaas J.M. Differential modulation of lateral septal vasopressin receptor blockade in spatial learning, social recognition, and anxiety-related behaviors in rats. Behav. Brain Res. 99 (1999) 7-16
113. Farini F. Diabete insipido ed opoterapia. Gazz Osped Clin. 34 (1913) 1135-1139
114. Ferris C.F., Albers H.E., Wesolowski S.M., Goldman B.D., and Luman S.E. Vasopressin injected into the hypothalamus triggers a stereotypic behavior in golden hamsters. Science 224 (1984) 521-523
115. Ferris C.F., Axelson J.F., Martin A.M., and Roberge L.F. Vasopressin immunoreactivity in the anterior hypothalamus is altered during the establishment of dominant/subordinate relationships between hamsters. Neuroscience 29 (1989) 675-683
116. Ferris C.F., Delville Y., Grzonka Z., Luber-Narod J., and Insel T.R. An iodinated vasopressin (V1) antagonist blocks flank marking and selectively labels neural binding sites in golden hamsters. Physiol. Behav. 54 (1993) 737-747
117. Ferris C.F., Lu S.F., Messenger T., Guillon C.D., Heindel N., et al. Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior. Pharmacol. Biochem. Behav. 83 (2006) 169-174
118. Ferris C.F., Meenan D.M., Axelson J.F., and Albers H.E. A vasopressin antagonist can reverse dominant/subordinate behavior in hamsters. Physiol. Behav. 38 (1986) 135-138
119. Ferris C.F., Melloni Jr. R.H., Koppel G., Perry K.W., Fuller R.W., et al. Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J. Neurosci. 17 (1997) 4331-4340
120. Ferris C.F., and Potegal M. Vasopressin receptor blockade in the anterior hypothalamus suppresses aggression in hamsters. Physiol. Behav. 44 (1988) 235-239
121. Ferris C.F., Rasmussen M.F., Messenger T., and Koppel G. Vasopressin-dependent flank marking in golden hamsters is suppressed by drugs used in the treatment of obsessive-compulsive disorder. BMC Neurosci. 2 (2001) 10
122. Ferris C.F., Singer E.A., Meenan D.M., and Albers H.E. Inhibition of vasopressin-stimulated flank marking behavior by V1-receptor antagonists. Eur. J. Pharmacol. 154 (1988) 153-159
123. Ferris C.F., Stolberg T., and Delville Y. Serotonin regulation of aggressive behavior in male golden hamsters (Mesocricetus auratus). Behav. Neurosci. 113 (1999) 804-815
124. Fetissov S.O., Hallman J., Nilsson I., Lefvert A.K., Oreland L., et al. Aggressive behavior linked to corticotropin-reactive autoantibodies. Biol. Psychiatry 60 (2006) 799-802
125. Fink S., Excoffier L., and Heckel G. Mammalian monogamy is not controlled by a single gene. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 10956-10960
126. Foletta V.C., Brown F.D., and Young III W.S. Cloning of rat ARHGAP4/C1, a RhoGAP family member expressed in the nervous system that colocalizes with the Golgi complex and microtubules. Brain Res. Mol. Brain Res. 107 (2002) 65-79
127. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J. Autism Dev. Disord. 33 (2003) 365-382
128. Frazier C.R., Trainor B.C., Cravens C.J., Whitney T.K., and Marler C.A. Paternal behavior influences development of aggression and vasopressin expression in male California mouse offspring. Horm. Behav. 50 (2006) 699-707
129. Fujiwara M., Ohgami Y., Inada K., and Iwasaki K. Effect of active fragments of arginine-vasopressin on the disturbance of spatial cognition in rats. Behav. Brain Res. 83 (1997) 91-96
130. Fujiwara Y., Hiroyama M., Sanbe A., Yamauchi J., Tsujimoto G., et al. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice. J. Endocrinol. 192 (2007) 361-369
131. Funabashi T., Shinohara K., Mitsushima D., and Kimura F. Estrogen increases arginine-vasopressin V1a receptor mRNA in the preoptic area of young but not of middle-aged female rats. Neurosci. Lett. 285 (2000) 205-208
132. Gaffori O.J., and De Wied D. Time-related memory effects of vasopressin analogues in rats. Pharmacol. Biochem. Behav. 25 (1986) 1125-1129
133. Gainer H., Fields R.L., and House S.B. Vasopressin gene expression: experimental models and strategies. Exp. Neurol. 171 (2001) 190-199
134. Gais S., Sommer M., Fischer S., Perras B., and Born J. Post-trial administration of vasopressin in humans does not enhance memory formation (vasopressin and memory consolidation). Peptides 23 (2002) 581-583
135. Geller B., Tillman R., Badner J.A., and Cook Jr. E.H. Are the arginine vasopressin V1a receptor microsatellites related to hypersexuality in children with a prepubertal and early adolescent bipolar disorder phenotype?. Bipolar Disord. 7 (2005) 610-616
136. Gerkema M.P., Van der Zee E.A., and Feitsma L.E. Expression of circadian rhythmicity correlates with the number of arginine-vasopressin-immunoreactive cells in the suprachiasmatic nucleus of common voles, Microtus arvalis. Brain Res. 639 (1994) 93-101
137. Gobrogge K.L., Liu Y., Jia X., and Wang Z. Anterior hypothalamic neural activation and neurochemical associations with aggression in pair-bonded male prairie voles. J. Comp. Neurol. 502 (2007) 1109-1122
138. Goekoop J.G., de Winter R.P., de Rijk R., Zwinderman K.H., Frankhuijzen-Sierevogel A., et al. Depression with above-normal plasma vasopressin: validation by relations with family history of depression and mixed anxiety and retardation. Psychiatry Res. 141 (2006) 201-211
139. Gold P.W., Goodwin F.K., and Reus V.I. Vasopressin in affective illness. Lancet 1 (1978) 1233-1236
140. Grant F.D. Genetic models of vasopressin deficiency. Exp. Physiol. 85 Spec. No. (2000) 203S-209S
141. Griebel G., Simiand J., Serradeil-Le Gal C., Wagnon J., Pascal M., et al. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 6370-6375
142. Grimes J.M., Ricci L.A., and Melloni Jr. R.H. Plasticity in anterior hypothalamic vasopressin correlates with aggression during anabolic-androgenic steroid withdrawal in hamsters. Behav. Neurosci. 120 (2006) 115-124
143. Grimmelikhuijzen C.J., and Spencer A.N. FMRFamide immunoreactivity in the nervous system of the medusa Polyorchis penicillatus. J. Comp. Neurol. 230 (1984) 361-371
144. Grmec S., and Mally S. Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: a observational cohort study. Crit. Care 10 (2006) R13
145. Groblewski T.A., Nunez A.A., and Gold R.M. Circadian rhythms in vasopressin deficient rats. Brain Res. Bull. 6 (1981) 125-130
146. Guillon C.D., Koppel G., Brownstein M.J., Chaney M.O., Ferris C.F., et al. Azetidinones as vasopressin V1a antagonists. Bioorg. Med. Chem. 15 (2007) 2054-2080
147. Gulpinar M.A., and Yegen B.C. The physiology of learning and memory: role of peptides and stress. Curr. Protein Pept. Sci. 5 (2004) 457-473
148. Hallbeck M., Hermanson O., and Blomqvist A. Distribution of preprovasopressin mRNA in the rat central nervous system. J. Comp. Neurol. 411 (1999) 181-200
149. Hamburger-Bar R., Eisenberg J., and Belmaker R.H. Animal and clinical studies of vasopressin effects on learning and memory. Isr. J. Med. Sci. 23 (1987) 12-18
150. Hamburger-Bar R., Klein A., and Belmaker R.H. The effect of chronic vs. acute injection of vasopressin on animal learning and memory. Peptides 6 (1985) 23-25
151. Hammock E.A., and Young L.J. Functional microsatellite polymorphism associated with divergent social structure in vole species. Mol. Biol. Evol. 21 (2004) 1057-1063
152. Hammock E.A., and Young L.J. Microsatellite instability generates diversity in brain and sociobehavioral traits. Science 308 (2005) 1630-1634
153. Hammock E.A., and Young L.J. Oxytocin, vasopressin and pair bonding: implications for autism. Phil. Trans. R. Soc. Lond. B: Biol. Sci. 361 (2006) 2187-2198
154. Hara Y., Battey J., and Gainer H. Structure of mouse vasopressin and oxytocin genes. Brain Res. Mol. Brain Res. 8 (1990) 319-324
155. Harrison R.J., Connor D.F., Nowak C., Nash K., and Melloni Jr. R.H. Chronic anabolic-androgenic steroid treatment during adolescence increases anterior hypothalamic vasopressin and aggression in intact hamsters. Psychoneuroendocrinology 25 (2000) 317-338
156. Hernando F., Schoots O., Lolait S.J., and Burbach J.P. Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin. Endocrinology 142 (2001) 1659-1668
157. Hiroyama M., Aoyagi T., Fujiwara Y., Birumachi J., Shigematsu Y., et al. Hypermetabolism of fat in V1a vasopressin receptor knockout mice. Mol. Endocrinol. 21 (2007) 247-258
158. Hofman M.A., and Swaab D.F. Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Res. 651 (1994) 134-142
159. Howl J., Wang X., Kirk C.J., and Wheatley M. Fluorescent and biotinylated linear peptides as selective bifunctional ligands for the V1a vasopressin receptor. Eur. J. Biochem. 213 (1993) 711-719
160. Hruby V.J., Chow M.S., and Smith D.D. Conformational and structural considerations in oxytocin-receptor binding and biological activity. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 501-534
161. Hu S.B., Zhao Z.S., Yhap C., Grinberg A., Huang S.P., et al. Vasopressin receptor 1a-mediated negative regulation of B cell receptor signaling. J. Neuroimmunol. 135 (2003) 72-81
162. Hut R.A., Van der Zee E.A., Jansen K., Gerkema M.P., and Daan S. Gradual reappearance of post-hibernation circadian rhythmicity correlates with numbers of vasopressin-containing neurons in the suprachiasmatic nuclei of European ground squirrels. J. Comp. Physiol. B 172 (2002) 59-70
163. Inder W.J., Donald R.A., Prickett T.C., Frampton C.M., Sullivan P.F., et al. Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression. Biol. Psychiatry 42 (1997) 744-747
164. Insel T.R. Is social attachment an addictive disorder?. Physiol. Behav. 79 (2003) 351-357
165. Insel T.R., Wang Z.X., and Ferris C.F. Patterns of brain vasopressin receptor distribution associated with social organization in microtine rodents. J. Neurosci. 14 (1994) 5381-5392
166. Insel T.R., Winslow J.T., Williams J.R., Hastings N., Shapiro L.E., et al. The role of neurohypophyseal peptides in the central mediation of complex social processes-evidence from comparative studies. Regul. Pept. 45 (1993) 127-131
167. Ishunina T.A., and Swaab D.F. Neurohypophyseal peptides in aging and Alzheimer's disease. Ageing Res. Rev. 1 (2002) 537-558
168. Itoh S., Yamada S., Mori T., Miwa T., Tottori K., et al. Attenuated stress-induced catecholamine release in mice lacking the vasopressin V1b receptor. Am. J. Physiol. Endocrinol. Metab. 291 (2006) E147-E151
169. Izquierdo L.A., Barros D.M., Medina J.H., and Izquierdo I. Stress hormones enhance retrieval of fear conditioning acquired either one day or many months before. Behav. Pharmacol. 13 (2002) 203-213
170. Jansen K., Van der Zee E.A., and Gerkema M.P. Organotypic suprachiasmatic nuclei cultures of adult voles reflect locomotor behavior: differences in number of vasopressin cells. Chronobiol. Int. 16 (1999) 745-750
171. Jansen K., Van der Zee E.A., and Gerkema M.P. Being circadian or not: vasopressin release in cultured SCN mirrors behavior in adult voles. Neuroreport 11 (2000) 3555-3558
172. Jard S., Barberis C., Audigier S., and Tribollet E. Neurohypophyseal hormone receptor systems in brain and periphery. Prog. Brain Res. 72 (1987) 173-187
173. Johnson A.E., Audigier S., Rossi F., Jard S., Tribollet E., et al. Localization and characterization of vasopressin binding sites in the rat brain using an iodinated linear AVP antagonist. Brain Res. 622 (1993) 9-16
174. Johnson A.E., Barberis C., and Albers H.E. Castration reduces vasopressin receptor binding in the hamster hypothalamus. Brain Res. 674 (1995) 153-158
175. Kalamatianos T., Kallo I., and Coen C.W. Ageing and the diurnal expression of the mRNAs for vasopressin and for the V1a and V1b vasopressin receptors in the suprachiasmatic nucleus of male rats. J. Neuroendocrinol. 16 (2004) 493-501
176. Kalsbeek A., Palm I.F., La Fleur S.E., Scheer F.A., Perreau-Lenz S., et al. SCN outputs and the hypothalamic balance of life. J. Biol. Rhythms. 21 (2006) 458-469
177. Kalsbeek A., Perreau-Lenz S., and Buijs R.M. A network of (autonomic) clock outputs. Chronobiol. Int. 23 (2006) 521-535
178. Keck M.E., Wigger A., Welt T., Muller M.B., Gesing A., et al. Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology 26 (2002) 94-105
179. Keverne E.B., and Curley J.P. Vasopressin, oxytocin and social behaviour. Curr. Opin. Neurobiol. 14 (2004) 777-783
180. Kim S.J., Young L.J., Gonen D., Veenstra-VanderWeele J., Courchesne R., et al. Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism. Mol. Psychiatry 7 (2002) 503-507
181. Kleiman D.G. Monogamy in mammals. Q. Rev. Biol. 52 (1977) 39-69
182. Koob G.F., Lebrun C., Bluthe R.M., Dantzer R., and Le Moal M. Role of neuropeptides in learning versus performance: focus on vasopressin. Brain Res. Bull. 23 (1989) 359-364
183. Koshimizu T.A., Nasa Y., Tanoue A., Oikawa R., Kawahara Y., et al. V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 7807-7812
184. Kovacs G.L., Buijs R.M., Bohus B., and van Wimersma Greidanus T.B. Microinjection of arginine8-vasopressin antiserum into the dorsal hippocampus attenuates passive avoidance behavior in rats. Physiol. Behav. 28 (1982) 45-48
185. Kovacs G.L., Veldhuis H.D., Versteeg D.H., and De Wied D. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures. Brain Res. 371 (1986) 17-24
186. Laczi F., Gaffori O., De Kloet E.R., and De Wied D. Arginine-vasopressin content of hippocampus and amygdala during passive avoidance behavior in rats. Brain Res. 280 (1983) 309-315
187. Landgraf R. The involvement of the vasopressin system in stress-related disorders. CNS Neurol. Disord. Drug Targets 5 (2006) 167-179
188. Landgraf R., Frank E., Aldag J.M., Neumann I.D., Sharer C.A., et al. Viral vector-mediated gene transfer of the vole V1a vasopressin receptor in the rat septum: improved social discrimination and active social behaviour. Eur. J. Neurosci. 18 (2003) 403-411
189. Landgraf R., Gerstberger R., Montkowski A., Probst J.C., Wotjak C.T., et al. V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats. J. Neurosci. 15 (1995) 4250-4258
190. Landgraf R., Kessler M.S., Bunck M., Murgatroyd C., Spengler D., et al. Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vasopressin and glyoxalase-I. Neurosci. Biobehav. Rev. 31 (2007) 89-102
191. Landgraf R., Neumann I., and Pittman Q.J. Septal and hippocampal release of vasopressin and oxytocin during late pregnancy and parturition in the rat. Neuroendocrinology 54 (1991) 378-383
192. Landgraf R., Neumann I., Russell J.A., and Pittman Q.J. Push-pull perfusion and microdialysis studies of central oxytocin and vasopressin release in freely moving rats during pregnancy, parturition, and lactation. Ann. N.Y. Acad. Sci. 652 (1992) 326-339
193. Landgraf R., Wigger A., Holsboer F., and Neumann I.D. Hyper-reactive hypothalamo-pituitary-adrenocortical axis in rats bred for high anxiety-related behaviour. J. Neuroendocrinol. 11 (1999) 405-407
194. Liebsch G., Wotjak C.T., Landgraf R., and Engelmann M. Septal vasopressin modulates anxiety-related behaviour in rats. Neurosci. Lett. 217 (1996) 101-104
195. Lim M.M., Hammock E.A., and Young L.J. The role of vasopressin in the genetic and neural regulation of monogamy. J. Neuroendocrinol. 16 (2004) 325-332
196. Lim M.M., Wang Z., Olazabal D.E., Ren X., Terwilliger E.F., et al. Enhanced partner preference in a promiscuous species by manipulating the expression of a single gene. Nature 429 (2004) 754-757
197. Lim M.M., and Young L.J. Neuropeptidergic regulation of affiliative behavior and social bonding in animals. Horm. Behav. 50 (2006) 506-517
198. Liu R.Y., Zhou J.N., Hoogendijk W.J., van Heerikhuize J., Kamphorst W., et al. Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J. Neuropathol. Exp. Neurol. 59 (2000) 314-322
199. Lolait S.J., O'Carroll A.M., Mahan L.C., Felder C.C., Button D.C., et al. Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 6783-6787
200. Lolait S.J., Stewart L.Q., Jessop D.S., Young III W.S., and O'Carroll A.M. The hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptors. Endocrinology 148 (2007) 849-856
201. Lolait S.J., Stewart L.Q., Roper J.A., Harrison D.S., Jessop W., et al. Attenuated stress response to acute lipopolysaccharide challenge and ethanol administration in vasopressin V1b receptor knockout mice. J. Neuroendocrinol. 19 (2007) 543-551
202. Lonstein J.S., and De Vries G.J. Sex differences in the parental behaviour of adult virgin prairie voles: independence from gonadal hormones and vasopressin. J. Neuroendocrinol. 11 (1999) 441-449
203. Lonstein J.S., Rood B.D., and De Vries G.J. Unexpected effects of perinatal gonadal hormone manipulations on sexual differentiation of the extrahypothalamic arginine-vasopressin system in prairie voles. Endocrinology 146 (2005) 1559-1567
204. Lord C., Cook E.H., Leventhal B.L., and Amaral D.G. Autism spectrum disorders. Neuron 28 (2000) 355-363
205. Ma D.Q., Cuccaro M.L., Jaworski J.M., Haynes C.S., Stephan D.A., et al. Dissecting the locus heterogeneity of autism: significant linkage to chromosome 12q14. Mol. Psychiatry 12 (2007) 376-384
206. Manning M., and Sawyer W.H. Antagonists of vasopressin and oxytocin: current status and future perspective. In: Jard S., and Jamison R. (Eds). Vasopressin (1991), John Libbey Eurotext Ltd, France 297-309
207. Manning M., and Sawyer W.H. Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin. J. Recept. Res. 13 (1993) 195-214
208. Mayes C.R., Watts A.G., McQueen J.K., Fink G., and Charlton H.M. Gonadal steroids influence neurophysin II distribution in the forebrain of normal and mutant mice. Neuroscience 25 (1988) 1013-1022
209. Melloni Jr. R.H., Connor D.F., Hang P.T., Harrison R.J., and Ferris C.F. Anabolic-androgenic steroid exposure during adolescence and aggressive behavior in golden hamsters. Physiol. Behav. 61 (1997) 359-364
210. Menard J., and Treit D. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci. Biobehav. Rev. 23 (1999) 591-613
211. Merali Z., Kent P., Du L., Hrdina P., Palkovits M., et al. Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol. Psychiatry 59 (2006) 594-602
212. Meynen G., Unmehopa U.A., van Heerikhuize J.J., Hofman M.A., Swaab D.F., et al. Increased arginine vasopressin mRNA expression in the human hypothalamus in depression: A preliminary report. Biol. Psychiatry 60 (2006) 892-895
213. Mezey E., and Kiss J.Z. Coexpression of vasopressin and oxytocin in hypothalamic supraoptic neurons of lactating rats. Endocrinology 129 (1991) 1814-1820
214. Michell R.H., Kirk C.J., and Billah M.M. Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin. Biochem. Soc. Trans. 7 (1979) 861-865
215. Miczek K.A., Maxson S.C., Fish E.W., and Faccidomo S. Aggressive behavioral phenotypes in mice. Behav. Brain Res. 125 (2001) 167-181
216. Miller M.A., De Vries G.J., al-Shamma H.A., and Dorsa D.M. Decline of vasopressin immunoreactivity and mRNA levels in the bed nucleus of the stria terminalis following castration. J. Neurosci. 12 (1992) 2881-2887
217. Miller M.A., Urban J.H., and Dorsa D.M. Steroid dependency of vasopressin neurons in the bed nucleus of the stria terminalis by in situ hybridization. Endocrinology 125 (1989) 2335-2340
218. Mishima K., Tsukikawa H., Inada K., Fujii M., Iwasaki K., et al. Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze. Eur. J. Pharmacol. 427 (2001) 43-52
219. Mishima K., Tsukikawa H., Miura I., Inada K., Abe K., et al. Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze. Neuropharmacology 44 (2003) 541-552
220. Mlynarik M., Zelena D., Bagdy G., Makara G.B., and Jezova D. Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats. Horm. Behav. 51 (2007) 395-405
221. Mohr E., Schmitz E., and Richter D. A single rat genomic DNA fragment encodes both the oxytocin and vasopressin genes separated by 11 kilobases and oriented in opposite transcriptional directions. Biochimie 70 (1988) 649-654
222. Muller R.A. The study of autism as a distributed disorder. Ment. Retard. Dev. Disabil. Res. Rev. 13 (2007) 85-95
223. Murgatroyd C., Wigger A., Frank E., Singewald N., Bunck M., et al. Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety. J. Neurosci. 24 (2004) 7762-7770
224. Myers B.L., and Badia P. Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions. Neurosci. Biobehav. Rev. 19 (1995) 553-571
225. Nair H.P., and Young L.J. Vasopressin and pair-bond formation: genes to brain to behavior. Physiology (Bethesda) 21 (2006) 146-152
226. Nishimura H., and Fan Z. Regulation of water movement across vertebrate renal tubules. Comp. Biochem. Physiol. A: Mol. Integr. Physiol. 136 (2003) 479-498
227. O'Keefe J.A., Crowley R.S., Hrivnak P., Kim N.B., and Amico J.A. Effect of testosterone and its metabolites upon the level of vasopressin messenger ribonucleic acid in the hypothalamus of the hyperosmotically stimulated male rat. Neuroendocrinology 61 (1995) 405-411
228. O'Keefe J., and Dostrovsky J. The hippocampus as a spatial map. Preliminary evidence from unit activity in the freely-moving rat. Brain Res. 34 (1971) 171-175
229. Oliver G., and Schäfer E.A. On the Physiological Action of Extracts of Pituitary Body and certain other Glandular Organs: Preliminary Communication. J. Physiol. 18 (1895) 277-279
230. Oshikawa S., Tanoue A., Koshimizu T.A., Kitagawa Y., and Tsujimoto G. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach. Mol. Pharmacol. 65 (2004) 623-629
231. Ostrowski N.L., Lolait S.J., Bradley D.J., O'Carroll A.M., Brownstein M.J., et al. Distribution of V1a and V2 vasopressin receptor messenger ribonucleic acids in rat liver, kidney, pituitary and brain. Endocrinology 131 (1992) 533-535
232. Ostrowski N.L., Lolait S.J., and Young III W.S. Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature. Endocrinology 135 (1994) 1511-1528
233. Paban V., Soumireu-Mourat B., and Alescio-Lautier B. Behavioral effects of arginine8-vasopressin in the Hebb-Williams maze. Behav. Brain Res. 141 (2003) 1-9
234. Packard M.G., and Ettenberg A. Effects of peripherally injected vasopressin and des-glycinamide vasopressin on the extinction of a spatial learning task in rats. Regul. Pept. 11 (1985) 51-63
235. Parker K.J., and Lee T.M. Central vasopressin administration regulates the onset of facultative paternal behavior in microtus pennsylvanicus (meadow voles). Horm. Behav. 39 (2001) 285-294
236. Pena A., Murat B., Trueba M., Ventura M.A., Wo N.C., et al. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8. J. Med. Chem. 50 (2007) 835-847
237. Pena, A., Murat, B., Trueba, M., Ventura, M. A., Bertrand, G., et al. (2007b). Pharmacological and physiological characterization of d[Leu4, Lys8]Vasopressin, the first V1b selective agonist for rat vasopressin/oxytocin receptors. Endocrinology, e pub.
238. Perras B., Droste C., Born J., Fehm H.L., and Pietrowsky R. Verbal memory after three months of intranasal vasopressin in healthy old humans. Psychoneuroendocrinology 22 (1997) 387-396
239. Perreau-Lenz S., Pevet P., Buijs R.M., and Kalsbeek A. The biological clock: the bodyguard of temporal homeostasis. Chronobiol. Int. 21 (2004) 1-25
240. Phelps S.M., and Young L.J. Extraordinary diversity in vasopressin (V1a) receptor distributions among wild prairie voles (Microtus ochrogaster): patterns of variation and covariation. J. Comp. Neurol. 466 (2003) 564-576
241. Pietrowsky R., Fehm-Wolfsdorf G., Born J., and Fehm H.L. Effects of DGAVP on verbal memory. Peptides 9 (1988) 1361-1366
242. Planas B., Kolb P.E., Raskind M.A., and Miller M.A. Vasopressin and galanin mRNAs coexist in the nucleus of the horizontal diagonal band: a novel site of vasopressin gene expression. J. Comp. Neurol. 361 (1995) 48-56
243. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int. Pharmacodyn. Ther. 229 (1977) 327-336
244. Reppert S.M., Schwartz W.J., Artman H.G., and Fisher D.A. Comparison of the temporal profiles of vasopressin and oxytocin in the cerebrospinal fluid of the cat, monkey and rat. Brain Res. 261 (1983) 341-345
245. Robinson A.G. DDAVP in the treatment of central diabetes insipidus. N. Engl. J. Med. 294 (1976) 507-511
246. Roche K.E., and Leshner A.I. ACTH and vasopressin treatments immediately after a defeat increase future submissiveness in male mice. Science 204 (1979) 1343-1344
247. Saito M., Sugimoto T., Tahara A., and Kawashima H. Molecular cloning and characterization of rat V1b vasopressin receptor: evidence for its expression in extra-pituitary tissues. Biochem. Biophys. Res. Commun. 212 (1995) 751-757
248. Saito M., Tahara A., and Sugimoto T. 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor. Biochem. Pharmacol. 53 (1997) 1711-1717
249. Saito T., Ishikawa S., Abe K., Kamoi K., Yamada K., et al. Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J. Clin. Endocrinol. Metab. 82 (1997) 1054-1057
250. Salome N., Stemmelin J., Cohen C., and Griebel G. Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats. Psychopharmacology (Berlin) 187 (2006) 237-244
251. Sato T., Ishida T., Irifune M., Tanaka K., Hirate K., et al. Effect of NC-1900, an active fragment analog of arginine vasopressin, and inhibitors of arachidonic acid metabolism on performance of a passive avoidance task in mice. Eur. J. Pharmacol. 560 (2007) 36-41
252. Sebat J., Lakshmi B., Malhotra D., Troge J., Lese-Martin C., et al. Strong association of de novo copy number mutations with autism. Science 316 (2007) 445-449
253. Serradeil-Le Gal C., Derick S., Brossard G., Manning M., Simiand J., et al. Functional and pharmacological characterization of the first specific agonist and antagonist for the V1b receptor in mammals. Stress 6 (2003) 199-206
254. Serradeil-Le Gal C., Wagnon J., Tonnerre B., Roux R., Garcia G., et al. An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders. CNS Drug Rev. 11 (2005) 53-68
255. Serradeil-Le Gal C., Wagnon J., Valette G., Garcia G., Pascal M., et al. Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands. Prog. Brain Res. 139 (2002) 197-210
256. Serradeil-Le Gal C., Wagnon J., Simiand J., Griebel G., Lacour C., et al. Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl) -2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist. J. Pharmacol. Exp. Ther. 300 (2002) 1122-1130
257. Shapiro R.A., Xu C., and Dorsa D.M. Differential transcriptional regulation of rat vasopressin gene expression by estrogen receptor alpha and beta. Endocrinology 141 (2000) 4056-4064
258. Sheline Y.I., Gado M.H., and Price J.L. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 9 (1998) 2023-2028
259. Shimazaki T., Iijima M., and Chaki S. The pituitary mediates the anxiolytic-like effects of the vasopressin V1B receptor antagonist, SSR149415, in a social interaction test in rats. Eur. J. Pharmacol. 543 (2006) 63-67
260. Siegel H.I. Aggressive Behavior. In: Siegel H.I. (Ed). The Hamster: Reproduction and Behavior (1985), Plenum Press, New York 261-286
261. Stemmelin J., Lukovic L., Salome N., and Griebel G. Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415. Neuropsychopharmacology 30 (2005) 35-42
262. Stribley J.M., and Carter C.S. Developmental exposure to vasopressin increases aggression in adult prairie voles. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 12601-12604
263. Sullivan P.F., Neale M.C., and Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 157 (2000) 1552-1562
264. Szot P., Bale T.L., and Dorsa D.M. Distribution of messenger RNA for the vasopressin V1a receptor in the CNS of male and female rats. Brain Res. Mol. Brain Res. 24 (1994) 1-10
265. Taga C., Sugimoto Y., Nishiga M., Fujii Y., and Kamei C. Effects of vasopressin on histamine H(1) receptor antagonist-induced spatial memory deficits in rats. Eur. J. Pharmacol. 423 (2001) 167-170
266. Tanoue A., Ito S., Honda K., Oshikawa S., Kitagawa Y., et al. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J. Clin. Invest. 113 (2004) 302-309
267. Tecott L.H. The genes and brains of mice and men. Am. J. Psychiatry 160 (2003) 646-656
268. Thibonnier M., Coles P., Thibonnier A., and Shoham M. Molecular pharmacology and modeling of vasopressin receptors. Prog. Brain Res. 139 (2002) 179-196
269. Thompson R., Gupta S., Miller K., Mills S., and Orr S. The effects of vasopressin on human facial responses related to social communication. Psychoneuroendocrinology 29 (2004) 35-48
270. Thompson R.R., George K., Walton J.C., Orr S.P., and Benson J. Sex-specific influences of vasopressin on human social communication. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 7889-7894
271. Tribollet E., Barberis C., and Arsenijevic Y. Distribution of vasopressin and oxytocin receptors in the rat spinal cord: sex-related differences and effect of castration in pudendal motor nuclei. Neuroscience 78 (1997) 499-509
272. Tuppy H. The amino-acid sequence in oxytocin. Biochim. Biophys. Acta 11 (1953) 449-450
273. Turner R.A., Pierce J.G., and Du Vigneaud V. The purification and the animo acid content of vasopressin preparations. J. Biol. Chem. 191 (1951) 21-28
274. Vaccari C., Lolait S.J., and Ostrowski N.L. Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain. Endocrinology 139 (1998) 5015-5033
275. Van der Veen D.R., Castillo M.R., Van der Zee E.A., Jansen K., Gerkema M.P., et al. Circadian dynamics of vasopressin in mouse selection lines: translation and release in the SCN. Brain Res. 1060 (2005) 16-25
276. Van der Zee E.A., Jansen K., and Gerkema M.P. Severe loss of vasopressin-immunoreactive cells in the suprachiasmatic nucleus of aging voles coincides with reduced circadian organization of running wheel activity. Brain Res. 816 (1999) 572-579
277. van Leeuwen F.W., Caffe A.R., and De Vries G.J. Vasopressin cells in the bed nucleus of the stria terminalis of the rat: sex differences and the influence of androgens. Brain Res. 325 (1985) 391-394
278. van Londen L., Goekoop J.G., van Kempen G.M., Frankhuijzen-Sierevogel A.C., Wiegant V.M., et al. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 17 (1997) 284-292
279. Van Someren E.J. Circadian rhythms and sleep in human aging. Chronobiol. Int. 17 (2000) 233-243
280. van West D., Del-Favero J., Aulchenko Y., Oswald P., Souery D., et al. A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression. Mol. Psychiatry 9 (2004) 287-292
281. Vawter M.P., De Wied D., and Van Ree J.M. Vasopressin fragment, AVP-(4-8), improves long-term and short-term memory in the hole board search task. Neuropeptides 31 (1997) 489-494
282. Veenema A.H., Blume A., Niederle D., Buwalda B., and Neumann I.D. Effects of early life stress on adult male aggression and hypothalamic vasopressin and serotonin. Eur. J. Neurosci. 24 (2006) 1711-1720
283. Virkkunen M., Rawlings R., Tokola R., Poland R.E., Guidotti A., et al. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch. Gen. Psychiatry 51 (1994) 20-27
284. Vongraven D. Die nierenwirkung von hypophysenextrakten meschen. Berl. Klin. Wochenscgr. 50 (1913) 2083-2086
285. Wang Z., Bullock N.A., and De Vries G.J. Sexual differentiation of vasopressin projections of the bed nucleus of the stria terminals and medial amygdaloid nucleus in rats. Endocrinology 132 (1993) 2299-2306
286. Wang Z., and De Vries G.J. Testosterone effects on paternal behavior and vasopressin immunoreactive projections in prairie voles (Microtus ochrogaster). Brain Res. 631 (1993) 156-160
287. Wang Z., and De Vries G.J. Androgen and estrogen effects on vasopressin messenger RNA expression in the medial amygdaloid nucleus in male and female rats. J. Neuroendocrinol. 7 (1995) 827-831
288. Wang Z., Ferris C.F., and De Vries G.J. Role of septal vasopressin innervation in paternal behavior in prairie voles (Microtus ochrogaster). Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 400-404
289. Wang Z., Liu Y., Young L.J., and Insel T.R. Hypothalamic vasopressin gene expression increases in both males and females postpartum in a biparental rodent. J. Neuroendocrinol. 12 (2000) 111-120
290. Wang Z., Toloczko D., Young L.J., Moody K., Newman J.D., et al. Vasopressin in the forebrain of common marmosets (Callithrix jacchus): studies with in situ hybridization, immunocytochemistry and receptor autoradiography. Brain Res. 768 (1997) 147-156
291. Wang Z.X., Liu Y., Young L.J., and Insel T.R. Hypothalamic vasopressin gene expression increases in both males and females postpartum in a biparental rodent. J. Neuroendocrinol. 12 (2000) 111-120
292. Wang Z., Young L.J., De Vries G.J., and Insel T.R. Voles and vasopressin: a review of molecular, cellular, and behavioral studies of pair bonding and paternal behaviors. Prog. Brain Res. 119 (1998) 483-499
293. Wassink T.H., Piven J., Vieland V.J., Pietila J., Goedken R.J., et al. Examination of AVPR1a as an autism susceptibility gene. Mol. Psychiatry 9 (2004) 968-972
294. Wenzel V., Krismer A.C., Arntz H.R., Sitter H., Stadlbauer K.H., et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N. Engl. J. Med. 350 (2004) 105-113
295. Wersinger S.R., Caldwell H.K., Christiansen M., and Young III W.S. Disruption of the vasopressin 1b receptor gene impairs the attack component of aggressive behavior in mice. Genes Brain Behav. 6 (2007) 653-660
296. Wersinger S.R., Caldwell H.K., Martinez L., Gold P., Hu S.B., et al. Vasopressin 1a receptor knockout mice have a subtle olfactory deficit but normal aggression. Genes Brain Behav. 6 (2007) 540-551
297. Wersinger, S.R., Temple, J.L., Caldwell, H.K., Young, W.S. 3rd. (2007c) Inactivation of the oxytocin and the vasopressin 1b receptor genes, but not the vasopressin 1a receptor gene, differentially impair the Bruce effect in laboratory mice (Mus musculus). Endocrinology [Epub Oct 18].
298. Wersinger S.R., Ginns E.I., O'Carroll A.M., Lolait S.J., and Young III W.S. Vasopressin V1b receptor knockout reduces aggressive behavior in male mice. Mol. Psychiatry 7 (2002) 975-984
299. Wersinger S.R., Kelliher K.R., Zufall F., Lolait S.J., O'Carroll A.M., et al. Social motivation is reduced in vasopressin 1b receptor null mice despite normal performance in an olfactory discrimination task. Horm. Behav. 46 (2004) 638-645
300. West C.H., and Weiss J.M. A selective test for antidepressant treatments using rats bred for stress-induced reduction of motor activity in the swim test. Psychopharmacology (Berlin) 182 (2005) 9-23
301. Wigger A., Sanchez M.M., Mathys K.C., Ebner K., Frank E., et al. Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin. Neuropsychopharmacology 29 (2004) 1-14
302. Williams J.R., Insel T.R., Harbaugh C.R., and Carter C.S. Oxytocin administered centrally facilitates formation of a partner preference in female prairie voles (Microtus ochrogaster). J. Neuroendocrinol. 6 (1994) 247-250
303. Winslow J.T., and Camacho F. Cholinergic modulation of a decrement in social investigation following repeated contacts between mice. Psychopharmacology (Berlin) 121 (1995) 164-172
304. Winslow J.T., Hastings N., Carter C.S., Harbaugh C.R., and Insel T.R. A role for central vasopressin in pair bonding in monogamous prairie voles. Nature 365 (1993) 545-548
305. Wong F., Blei A.T., Blendis L.M., and Thuluvath P.J. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Hepatology 37 (2003) 182-191
306. Wotjak C.T., Ganster J., Kohl G., Holsboer F., Landgraf R., et al. Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons. Neuroscience 85 (1998) 1209-1222
307. Wotjak C.T., Kubota M., Liebsch G., Montkowski A., Holsboer F., et al. Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion?. J. Neurosci. 16 (1996) 7725-7732
308. Yang M.S., and Gill M. A review of gene linkage, association and expression studies in autism and an assessment of convergent evidence. Int. J. Dev. Neurosci. 25 (2007) 69-85
309. Yirmiya N., Rosenberg C., Levi S., Salomon S., Shulman C., et al. Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills. Mol. Psychiatry 11 (2006) 488-494
310. Young, L.J. and Hammock, E.A. (2007). On switches and knobs, microsatellites and monogamy. Trends Genet, [Epub Mar 6].
311. Young L.J., Murphy Young A.Z., and Hammock E.A. Anatomy and neurochemistry of the pair bond. J. Comp. Neurol. 493 (2005) 51-57
312. Young L.J., Nilsen R., Waymire K.G., MacGregor G.R., and Insel T.R. Increased affiliative response to vasopressin in mice expressing the V1a receptor from a monogamous vole. Nature 400 (1999) 766-768
313. Young L.J., and Wang Z. The neurobiology of pair bonding. Nat. Neurosci. 7 (2004) 1048-1054
314. Young L.J., Wang Z., Cooper T.T., and Albers H.E. Vasopressin (V1a) receptor binding, mRNA expression and transcriptional regulation by androgen in the Syrian hamster brain. J. Neuroendocrinol 12 (2000) 1179-1185
315. Young III W.S., and Gainer H. Transgenesis and the study of expression, cellular targeting and function of oxytocin, vasopressin and their receptors. Neuroendocrinology 78 (2003) 185-203
316. Young III W.S., Kovacs K., and Lolait S.J. The diurnal rhythm in vasopressin V1a receptor expression in the suprachiasmatic nucleus is not dependent on vasopressin. Endocrinology 133 (1993) 585-590
317. Young III W.S., Li J., Wersinger S.R., and Palkovits M. The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy. Neuroscience 143 (2006) 1031-1039
318. Yun J., Schoneberg T., Liu J., Schulz A., Ecelbarger C.A., et al. Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene. J. Clin. Invest. 106 (2000) 1361-1371
319. Zhou J.N., Riemersma R.F., Unmehopa U.A., Hoogendijk W.J., van Heerikhuize J.J., et al. Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Arch. Gen. Psychiatry 58 (2001) 655-662
320. Zhou L., Blaustein J.D., and De Vries G.J. Distribution of androgen receptor immunoreactivity in vasopressin- and oxytocin-immunoreactive neurons in the male rat brain. Endocrinology 134 (1994) 2622-2627
321. Ziegler T.E. Hormones associated with non-maternal infant care: a review of mammalian and avian studies. Folia Primatol. (Basel) 71 (2000) 6-21